Centene Corporation
Centene Reaffirms 2024 Guidance and Discloses Conference Presentation Details
Summary
Centene Corporation announced its participation in the Bernstein 40th Annual Strategic Decisions Conference, scheduled for May 31, 2024. The company expects to reaffirm its 2024 full-year adjusted diluted EPS guidance of greater than $6.80 and the full-year consolidated health benefits ratio range of 87.3% to 87.9%. Centene also highlighted higher-than-expected claims receipts in its Medicaid segment for April 2024 and anticipated favorable performance in its Marketplace segment. The company will provide additional details during its second-quarter 2024 earnings call in late July.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement